Current status and future perspectives of radiomics in hepatocellular carcinoma

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
BAISHIDENG PUBLISHING GROUP INC
Autores
HORVAT, Natally
ARAUJO-FILHO, Jose de Arimateia Batista
FERNANDES, Maria Clara
CHARBEL, Charlotte
CHAKRABORTY, Jayasree
Citação
WORLD JOURNAL OF GASTROENTEROLOGY, v.29, n.1, p.43-60, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Given the frequent co-existence of an aggressive tumor and underlying chronic liver disease, the management of hepatocellular carcinoma (HCC) patients requires experienced multidisciplinary team discussion. Moreover, imaging plays a key role in the diagnosis, staging, restaging, and surveillance of HCC. Currently, imaging assessment of HCC entails the assessment of qualitative characteristics which are prone to inter-reader variability. Radiomics is an emerging field that extracts high-dimensional mineable quantitative features that cannot be assessed visually with the naked eye from medical imaging. The main potential applications of radiomic models in HCC are to predict histology, response to treatment, genetic signature, recurrence, and survival. Despite the encouraging results to date, there are challenges and limitations that need to be overcome before radiomics implementation in clinical practice. The purpose of this article is to review the main concepts and challenges pertaining to radiomics, and to review recent studies and potential applications of radiomics in HCC.
Palavras-chave
Radiomics, Hepatocellular carcinoma, Texture analysis, Radiology
Referências
  1. Akai H, 2018, DIAGN INTERV IMAG, V99, P643, DOI 10.1016/j.diii.2018.05.008
  2. Bakr S, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.041303
  3. Bera K, 2022, NAT REV CLIN ONCOL, V19, P132, DOI 10.1038/s41571-021-00560-7
  4. Blanc-Durand P, 2018, ONCOTARGET, V9, P4549, DOI 10.18632/oncotarget.23423
  5. Brancato V, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12051085
  6. Cai W, 2019, SURG ONCOL, V28, P78, DOI 10.1016/j.suronc.2018.11.013
  7. Carbonell G, 2022, EUR RADIOL, V32, P2030, DOI 10.1007/s00330-021-08282-1
  8. Che F, 2022, WORLD J GASTROENTERO, V28, P1479, DOI 10.3748/wjg.v28.i14.1479
  9. Chen MY, 2021, LIVER CANCER, V10, P38, DOI 10.1159/000512028
  10. Chen SL, 2019, EUR RADIOL, V29, P4177, DOI 10.1007/s00330-018-5986-x
  11. Chen W, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.660509
  12. Xia W, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaa609
  13. Xu X, 2019, J HEPATOL, V70, P1133, DOI 10.1016/j.jhep.2019.02.023
  14. Yang F, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.672126
  15. Yang L, 2019, LIVER CANCER, V8, P373, DOI 10.1159/000494099
  16. Ye Z, 2019, CHINESE J CANCER RES, V31, P806, DOI 10.21147/j.issn.1000-9604.2019.05.10
  17. Yuan GS, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613946
  18. Zhang HP, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12051043
  19. Zhang J, 2019, TRANSL CANCER RES, V8, P130, DOI 10.21037/tcr.2019.01.14
  20. Zhao Y, 2021, J MAGN RESON IMAGING, V53, P1066, DOI 10.1002/jmri.27424
  21. Zheng BH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5024-z
  22. Zheng J, 2017, J AM COLL SURGEONS, V225, P778, DOI 10.1016/j.jamcollsurg.2017.09.003
  23. Zhong X, 2022, ABDOM RADIOL, V47, P2071, DOI 10.1007/s00261-022-03496-3
  24. Zhou W, 2017, J MAGN RESON IMAGING, V45, P1476, DOI 10.1002/jmri.25454
  25. Zhou Y, 2017, ABDOM RADIOL, V42, P1695, DOI 10.1007/s00261-017-1072-0
  26. Zhu WS, 2020, WORLD J GASTROENTERO, V26, P1208, DOI 10.3748/wjg.v26.i11.1208
  27. Zhuo JY, 2020, J CANCER, V11, P5069, DOI 10.7150/jca.44697
  28. Chen YY, 2021, J HEPATOCELL CARCINO, V8, P795, DOI 10.2147/JHC.S313879
  29. Du M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-38
  30. Duan JH, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.881931
  31. Ezzoukhry Z, 2012, INT J CANCER, V131, P2961, DOI 10.1002/ijc.27604
  32. Fan YF, 2021, BMC MED IMAGING, V21, DOI 10.1186/s12880-021-00633-0
  33. Feng ST, 2019, EUR RADIOL, V29, P4648, DOI 10.1007/s00330-018-5935-8
  34. Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
  35. Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
  36. Gao F., 2018, J PHYS C SER, V1053
  37. Giger ML, 2018, J AM COLL RADIOL, V15, P512, DOI 10.1016/j.jacr.2017.12.028
  38. Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
  39. Guo DH, 2019, EUR J RADIOL, V117, P33, DOI 10.1016/j.ejrad.2019.05.010
  40. Haniff NSM, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11091573
  41. He XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08705
  42. Hectors SJ, 2020, EUR RADIOL, V30, P3759, DOI 10.1007/s00330-020-06675-2
  43. Herman P, 2022, CLINICS, V77, DOI 10.1016/j.clinsp.2022.100088
  44. Horvat N, 2022, ABDOM RADIOL, V47, P2972, DOI 10.1007/s00261-021-03359-3
  45. Horvat N, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e2888
  46. Hu HT, 2020, RADIOL MED, V125, P697, DOI 10.1007/s11547-020-01174-2
  47. Hu MJ, 2021, CLIN RADIOL, V76, DOI 10.1016/j.crad.2020.11.002
  48. Hu XM, 2022, CANCERS, V14, DOI 10.3390/cancers14112575
  49. Hui TCH, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2018.07.109
  50. Ibrahim A, 2021, CANCERS, V13, DOI 10.3390/cancers13184638
  51. Ivanics T, 2021, TRANSPLANTATION, V105, P2435, DOI 10.1097/TP.0000000000003605
  52. Ji GW, 2020, RADIOLOGY, V294, P568, DOI 10.1148/radiol.2020191470
  53. Perez MJ, 2020, WORLD J GASTROENTERO, V26, P5617, DOI 10.3748/wjg.v26.i37.5617
  54. Kim J, 2018, AM J ROENTGENOL, V211, P1026, DOI 10.2214/AJR.18.19507
  55. Kim S, 2019, CLIN CANCER RES, V25, P3847, DOI 10.1158/1078-0432.CCR-18-2861
  56. Kiryu S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12688-7
  57. Kong CL, 2021, EUR RADIOL, V31, P7500, DOI 10.1007/s00330-021-07910-0
  58. Larue RTHM, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160665
  59. Lauwers GY, 2002, AM J SURG PATHOL, V26, P25, DOI 10.1097/00000478-200201000-00003
  60. Lewis S, 2019, ABDOM RADIOL, V44, P912, DOI 10.1007/s00261-019-01906-7
  61. Li XM, 2022, J CLIN TRANSL HEPATO, V10, P63, DOI 10.14218/JCTH.2021.00023
  62. Li Y, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2019.06.024
  63. Liao HT, 2022, ANN SURG ONCOL, V29, P4552, DOI 10.1245/s10434-022-11505-4
  64. Liao HT, 2019, ANN SURG ONCOL, V26, P4537, DOI 10.1245/s10434-019-07815-9
  65. Liu XY, 2022, AM J ROENTGENOL, V219, P985, DOI 10.2214/AJR.22.27695
  66. Liu XY, 2021, EUR RADIOL, V31, P244, DOI 10.1007/s00330-020-07119-7
  67. Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145
  68. Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
  69. Lopes FDLM, 2016, ABCD-ARQ BRAS CIR DI, V29, P105, DOI 10.1590/0102-6720201600020010
  70. Luo YH, 2015, INT J CLIN EXP MED, V8, P10235
  71. Lv X, 2021, EUR J RADIOL, V144, DOI 10.1016/j.ejrad.2021.109955
  72. Ma XH, 2019, EUR RADIOL, V29, P3595, DOI 10.1007/s00330-018-5985-y
  73. Ma YF, 2021, INT J MED SCI, V18, P1456, DOI 10.7150/ijms.51256
  74. Mantovani F, 2017, FEBS J, V284, P837, DOI 10.1111/febs.13948
  75. Mao B, 2020, EUR RADIOL, V30, P6924, DOI 10.1007/s00330-020-07056-5
  76. Mao YF, 2022, HEPATOBIL SURG NUTR, V11, P13, DOI 10.21037/hbsn-19-870
  77. Santos JMMM, 2020, ABDOM RADIOL, V45, P342, DOI 10.1007/s00261-019-02299-3
  78. Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29
  79. Mokrane FZ, 2020, EUR RADIOL, V30, P558, DOI 10.1007/s00330-019-06347-w
  80. Negri FV, 2015, LIVER INT, V35, P2001, DOI 10.1111/liv.12778
  81. Nie P, 2021, ACAD RADIOL, V28, P799, DOI 10.1016/j.acra.2020.04.027
  82. Nie P, 2020, CANCER IMAGING, V20, DOI 10.1186/s40644-020-00297-z
  83. Park S, 2023, ACTA RADIOL, V64, P907, DOI 10.1177/02841851221100318
  84. Perrin T, 2018, ABDOM RADIOL, V43, P3271, DOI 10.1007/s00261-018-1600-6
  85. Petukhova-Greenstein A, 2022, J VASC INTERV RADIOL, V33, P814, DOI 10.1016/j.jvir.2022.04.006
  86. Qiu QT, 2019, QUANT IMAG MED SURG, V9, P453, DOI 10.21037/qims.2019.03.02
  87. Rizzo Stefania, 2018, Eur Radiol Exp, V2, P36, DOI 10.1186/s41747-018-0068-z
  88. Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306
  89. Shan QY, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0197-5
  90. Shur JD, 2021, RADIOGRAPHICS, V41, P1717, DOI 10.1148/rg.2021210037
  91. Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI [10.3322/caac.21492, 10.3322/caac.21442, 10.3322/caac.21660]
  92. Song WL, 2020, J MAGN RESON IMAGING, V52, P461, DOI 10.1002/jmri.26977
  93. Sun YJ, 2020, J MAGN RESON IMAGING, V52, P1083, DOI 10.1002/jmri.27143
  94. Suzuki K, 2017, RADIOL PHYS TECHNOL, V10, P257, DOI 10.1007/s12194-017-0406-5
  95. Thawani R, 2018, LUNG CANCER, V115, P34, DOI 10.1016/j.lungcan.2017.10.015
  96. Tian YC, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11101875
  97. UEDA K, 1988, Acta Paediatrica Japonica, V30, P163
  98. van Timmeren JE, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-020-00887-2
  99. Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05
  100. Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
  101. Wagner MW, 2021, NEURORADIOLOGY, V63, P1957, DOI 10.1007/s00234-021-02813-9
  102. Wang HQ, 2019, EUR J RADIOL, V117, P164, DOI 10.1016/j.ejrad.2019.06.016
  103. Wang XH, 2022, COMPUT BIOL MED, V141, DOI 10.1016/j.compbiomed.2021.105058
  104. World Health Organization, CANC FACT SHEETS
  105. Wu CY, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.943942
  106. Wu HZ, 2019, METHOD INFORM MED, V58, P42, DOI 10.1055/s-0039-1688758
  107. Wu JJ, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0321-9
  108. Wu MH, 2019, EUR RADIOL, V29, P2802, DOI 10.1007/s00330-018-5787-2